Guidelines posters

VIII Spanish-Portuguese Conference on Controlled Drug Delivery
Alcalá de Henares, Madrid, Spain
Poster List
P01: CYCLODEXTRIN-BIOADHESIVE NANOPARTICLES FOR ORAL DELIVERY OF LIPOPHILIC
DRUGS
M. Agüeros, M.A. Campanero, J.M. Irache.
P02: INFLUENCE OF THE RHEOLOGICAL PROPERTIES OF TOPICAL EMULSIONS ON THE "IN
VITRO" SALILYLIC ACID DELIVERY PROFILE THROUGH HUMAN SKIN AND SYNTHETIC
MEMBRANE
Mª.E. Franco Gil, A.Mª. Rodríguez Bayón.
P03: SALICYLIC ACID RELEASE PROFILE COMPARATIVE STUDY THROUGH DIFFERENT TYPES
OF MEMBRANES USING DIFFERENCE (F2) AND SIMILARITY (F1) FACTORS
A.Mª. Rodríguez Bayón, S.H. Trujillo Cásares.
P04: SODIUN SALICYLATE, THEOPHYLINE AND BENZOIC ACID RELEASE FROM EUDRAGIT RS
PO MATRICES AS RELATED TO POLARITY
N. Aragón, P. Bustamante, B. Escalera, M.A. Peña.
P05: MACROPOROUS SOLID FOAMS PREPARED FROM HIGHLY CONCENTRATED
EMULSIONS AS VEHICLES FOR DRUG DELIVERY
R.M. Aparicio, C. Canal, M. Ribé, A. Vílchez, J. Esquena, M.J. García-Celma.
P06: CHITOSAN NANOPARTICLES AS METRONIDAZOLE DELIVERY SYSTEMS
J.L. Arias, G. Martínez-Soler, M. López-Viota, V. Gallardo.
P07: BIOADHESIVE PROPERTIES OF SUMATRIPTAN SUCCINATE TRANSDERMAL DELIVERY
SYSTEMS
C. Balaguer-Fernández, C. Padula, A. Femenía-Font, V. Merino, F. Marra, S. Nicoli, P.
Santi, A. López-Castellano.
P08: IN VITRO TRANSDERMAL ABSORPTION OF ALMOTRIPTAN THROUGH PORCINE SKIN
M.A. Calatayud-Pascual, S. del Rio-Sancho, C. Balaguer-Fernández, A. Femenía-Font,
V. Merino, A. López-Castellano.
P09: STUDIES ON THE ENCAPSULATION OF DEXAMETHASONE IN POLYMERIC
NANOPARTICLES OBTAINED BY NANO-EMULSION TEMPLATING
G. Calderó, R. Montes, M.J. García-Celma, M. Porras, C. Solans.
P10: PRELIMINARY EVALUATION OF CATOSTYLUS TAGI COLLAGEN IN THE PRODUCTION OF
PARTICULATE DRUG DELIVERY SYSTEMS
M.T. Calejo, L. Gonçalves, Z.B. Morais, A.I. Fernandes.

P11: PRELIMINAR DELIVERY STUDIES OF THREE DIFFERENT FORMULATIONS OF NYSTATIN
A.C. Calpena, E. Torres, J.L. Parra, C. Alonso.
P12: TISSUE ENZYMATIC DISAGGREGATION TO OBTAIN ENDOTHELIAL CELLS FOR
PHARMACOLOGICAL APPLICATIONS
C. Camañas-Troyano, J. Díaz Alonso, A. Fernández-Carballido, A. Serrano.
P13: CELECOXIB-LOADED NANOPARTICLES FOR THE COADJUVANT TREATMENT OF
PROSTATE CANCER
J. Molpeceres, M. Gutiérrez-Gómez, M.R. Aberturas.
P14: DEVELOPMENT AND CHARACTERIZATION OF MELOXICAM MICROSPHERES TO TREAT
OSTEOSARCOMA
C. Montejo, A. Aguilar, S. Timón, A. Fernández-Carballido.
P15: PLGA-PEG MELOXICAM MICROSPHERES: CYTOTOXICITY STUDY IN DIFFERENT CANCER
CELL LINES
C. Montejo, E. Barcia, A. Fernández-Carballido.
P16: PHOTOPHYSICAL STUDY OF THE EFFECT OF 2,2,2TRIFLUOROETHANOL ON MICELLES
PROPERTIES OF TX-100 IN AQUEOUS SOLUTION
C. Civera, F. García-Blanco, M.A. Elorza, I. Gómez-Escalonilla, B. Elorza, C. Arias, P.A.
Galera-Gómez.
P17: HYALURONIC ACID-CHITOSAN NANOPARTICLES TRAFFICKING ACROSS EPITHELIAL
CELLS FROM THE OCULAR SURFACE
L. Contreras-Ruiz, A. López-García, J.E. Párraga, M. de la Fuente, B. Seijo, M.J. Alonso,
M. Calonge, Y. Diebold.
P18: THE EFFECT OF HYDROXYPROPYL-(-CYCLODEXTRIN ON THE CHEMICAL STABILITY AND
THE AQUEOUS SOLUBILITY OF KETOPROFEN ENANTIOMERS
C. Álvarez, A.C. Moreno, J.J. Torrado.
P19: CHITOSAN-CYCLODEXTRIN NANOPARTICLES AS GENE DELIVERY NANOCARRIERS FOR
CELL CULTURE
C. Vila-Sanjurjo, F.M. Goycoolea, C. Remuñán-López, C. Gorzelanny, S.W. Schneider,
M.J. Alonso.
P20: INFLUENCE OF POLY (DL-LACTIDE ACID) ON THE PROPERTIES OF HYDROPHILIC GELS
CONTAINING CHITOSAN AND SODIUM CARBOXYMETHYLCELLULOSE
P.M. de la Torre, C. Álvarez, S. Torrado, G. Torrado.
P21: EFFECT OF MOISTURE SORPTION OF SMALL LEVELS OF IMPURITIES ON THE STABILITY OF
RANITIDINE HYDROCHLORIDE FORMULATIONS
G. Torrado, J. García Torrent, S. Torrado, P.M. de la Torre.
P22: CHITOSAN-HYALURONIC ACID NANOPARTICLES LOADED WITH HEPARIN FOR THE
TREATMENT OF ASTHMA
F.A. Oyarzun-Ampuero, D. Torres, M.J. Alonso.
P23: MODIFIED GENTAMICIN TO INCREASE CELLULAR UPTAKE
E. Imbuluzqueta, C. Gamazo, D. González, E. Elizondo, N. Ventosa, S. Sala, J. Veciana,
M.J. Blanco-Prieto.
P24: IMPROVEMENT OF THE MONITORING AND BIOSECURITY OF ENCAPSULATED
MYOBLASTS USING TK-GFP-luciferase PLASMID
E. Santos, G. Orive, R.M. Hernández, R. Catena, A. Calvo, J.L. Pedraz.

P25: ENCAPSULATION OF RGDS IN PLGA MICROPARTICLES
M. Guzmán, S. Viera, P. Gonçalves, M. Griera, M. Rodriguez-Puyol.
P26: ELABORATION AND CHARACTERIZATION OF GFP-PLGA MICROPARTICLES PRODUCED
BY FLOW FOCUSING TECHNOLOGY
M.J. Cózar-Bernal, M.A. Holgado, J. Alvarez-Fuentes, J.L. Arias, A. Gañán-Calvo, M.
Fernández-Arévalo.
P27: PREPARATION OF PARAMAGNETIC MICROPARTICLES FOR BIOMEDICAL APPLICTIONS
L. Martín-Banderas, M. Fernández-Arévalo, A. Gañán-Calvo.
P28: INFLUENCE OF NATURE POLYMER PROPERTIES ON THE SURFACE MICROPARTICLES
MORPHOLOGY
L. Martín-Banderas, M. Fernández-Arévalo, M. Flores-Mosquera, A. Gañán-Calvo.
P29: DEVELOPMENT OF A RAPID REVERSED-PHASE HPLC METHOD FOR THE DETERMINATION
OF GFP FROM PLGA-MICROPARTICLES
M.J. Cózar-Bernal, S. Salas, M.A. Holgado, J. Alvarez-Fuentes, M. Fernández-Arévalo.
P30: OPTIMIZATION OF KETOROLAC-LOADED PLGA MICROPARTICLES ELABORATION BY
O/W SOLVENT EMULSION/EVAPORATION TECHNIQUE.
J. Ascenção, I. Bravo-Osuna, J.A. Cardillo, R. Herrero-Vanrell, I.T. Molina-Martínez.
P31: IN VITRO RELEASE PROFILES OF BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF)
FROM PLGA MICROPARTICLES FOR INTRAVITREOUS ADMINISTRATION
S. Sacristán de la Obra, P. Checa-Casalengua, I.T. Molina-Martínez, R. Herrero-Vanrell, I.
Bravo-Osuna.
P32: STERILISATION OF PLGA MICROSPHERES LOADED WITH DEXAMETHASONE DESTINED
TO JUXTASCLERAL ADMINISTRATION.
D. Barbosa-Alfaro, M.T. García-Gutierrez, I. Fernández-Bueno, J.C. Pastor-Jimeno, I.T.
Molina-Martínez, R. Herrero-Vanrell.
P33: NEW FORMULATION BASED ON LIPOSOMES AND HYALURONIC ACID FOR THE
TREATMENT OF DRY EYE SYNDROME
M. Vicario, N. Girón, B. de las Heras, R. Herrero-Vanrell, M. Guzmán, J.M. Benítez del
Castillo, I.T. Molina-Martínez.
P34: COMPARATIVE STUDY OF THE CRITICAL POINTS OF HPMC K100 LV (125-180 µm) AND
HPMC K4M (125-180 µm) IN HYDROFILIC MATRICES
I. Caraballo, T. Gonçalves, C. Cifuentes, A.R. Rajabi-Siahboomi.
P35: IMPLANTATION OF GLP IN A CENTRE FOR PHARMACEUTICAL RESEARCH AND
DEVELOPMENT: IDENTIFICATION OF EQUIPMENT.
I. Caraballo, T. Gonçalves, V. Daza.
P36: THE ROLE OF NANOPARTICLES IN DRUG PERMEABILITY
Z. Piotrowska, M.R. Aberturas, J. Molpeceres.
P37: MICROENCAPSULATION AND AGGREGATION REDUCE THE TOXICITY BY HEMOLYSIS
OF DIFFERENT AMPHOTERICIN B FORMULATIONS
L. Fleire, D. Serrano, R. Espada, M.P. Ballesteros, J.J. Torrado.
P38: THERMAL CHARACTERIZATION OF NAPROXEN/ GELUCIRES GRANULES
M. Sáiz, R. Ruiz, T. Marras, P.L. Mamani, M.D. Veiga.

P39: EFFECT OF DRUG SOLUBILITY ON THE RELEASE BEHAVIOUR OF MATRIX TABLETS BASED
ON STARCH-METHACRYLIC COPOLYMERS
J.A. Marinich, C. Ferrero, M.J. Lucero, M.R. Jiménez-Castellanos.
P40: RHEOLOGICAL AND RELEASE PROPERTIES OF HYDROXYPROPYLCELLULOSE AND
EUDRAGIT(r) L100 AQUEOUS DISPERSION SYSTEM
M.D. Moya, J.M. Álvarez, M.J. Lucero.
P41: IMPORTANCE OF DRUG-MEMBRANE INTERACTION STUDIES FOR THE RATIONAL
DEVELOPMENT OF THERAPEUTIC APPLICATIONS.
M. Lúcio, C. Nunes, J.L.C. Lima, S. Reis.
P42: CYTOTOXICITY STUDIES OF A NEW POLY(MAGNESIUM) ACRYLATE HYDROGEL
M. Cheddadi, E. López-Cabarcos, J. Rubio-Retama, P. Pastoriza, A. Fernandez-
Carballido.
P43: DESIGN OF GRISEOFULVIN-LOADED L100 EUDRAGIT NANOPARTICLES FOR
IMPROVEMENT OF ORAL BIOAVAILABILITY
A.B.A. Majeed, R. Pereira, T. Julianto, K.H. Yuen.
P44: ENHANCED TRANSDERMAL DELIVERY OF ACYCLOVIR FROM LIPOSOMES: AN IN VITRO
STUDY
D. Córdoba, B. Elorza, R. Gutiérrez, M.A. Elorza, M. Córdoba-Díaz.
P45: POSITIVELY CHARGED LIPOSOMES CONTAINING SUMATRIPTAN: EFFECT OF THE
PREPARATION METHOD, STEARYLAMINE CONCENTRATION AND DRUG PRESENCE ON THE
PHYSICOCHEMICAL PROPERTIES OF VESICLES
M.L. González-Rodríguez, S. Villasmil, S. Salas, A.M. Rabasco.
P46: COMPARISON BETWEEN POSITIVELY AND NEGATIVELY CHARGED LIPOSOME OF
SUMATRIPTAN SUCCINATE: PREPARATION METHODS AND CHARACTERIZATION
M.L. González-Rodríguez, W. Dhrimeur, S. Villasmil, S. Salas, A.M. Rabasco.
P47: DEVELOPMENT, CHARACTERIZATION AND EVALUATION OF THE EFFECTIVENESS OF
MICROPARTICULES OF INSECTICIDE CYPERMETHRIN
C. Martín, P. Rivas, D. Fernandes, M.E. Gil, A.I. Torres.
P48: USING CARBOSILANE DENDRIMERS TO DELIVERY AND TRANSFECT OF siRNA INTO
LYMPHOCITES AND ASTROCYTOMA CELLS: POTENTIAL ALTERNATIVE THERAPY FOR HIV
N. Weber, J.L. Jiménez, Mª.I. Clemente, P. Ortega, F.J. de la Mata, R. Gómez, M.A.
Muñoz-Fernández.
P49: WATER-STABLE CARBOSILANE DENDRIMERS AS NON VIRAL VEHICLES FOR GENE
THERAPY AGAINST HIV.
F.J. de la Mata, B. Rasines, N. de las Cuevas, R. Gómez, M.A. Muñoz-Fernández.
STABILITY OF LIPOSOMES TRIAMCINOLONE ACETONIDE: COMPARATIVE STUDY OF
ANTIOXIDANT EFFECT OF VITAMIN E AND WATER-SOLUBLE VITAMIN E
B. Clares, M.M. Medina.
P51: ENHANCED THERAPEUTIC EFFECT OF PAROMOMYCIN LIPOSOMES IN A MURINE M.
AVIUM MODEL OF INFECTION
M.M. Gaspar, A.C. Sousa, M.E.M. Cruz.

P52: EFFICACY STUDIES OF FORMULATIONS WITH DIFFERENT RATIOS OF AMPHOTERICIN B
AND SODIUM DEOXYCHOLATE
A.C. Moreno Rodríguez, G. Molero Martín-Portugués, S. Torrado Durán, P.M. de la Torre
Iglesias.
P53: EFFICACY OF NEW PLGA NANOPARTICLES OF CISPLATIN IN AN ANIMAL MODEL.
D. Moreno, S. Zalba, I. Navarro, C. Tros de Ilarduya, E. Bandrés, M.J. Garrido.
P54: A COMPARATIVE STUDY ON KETOPROFEN ENCAPSULATION AND RELEASE IN NANO-
EMULSIONS AND POLY(ETHERURETHANE) NANOPARTICLES
G. Morral, C. Solans, M.L. García, M.J. García.
P55: XENOGENEIC TRANSPLANTATION OF EPO-SECRETING MURINE CELLS IMMOBILIZED IN
MICROCAPSULES USING TRANSIENT IMMUNOSUPPRESSION IN FISHER RATS
A. Murua, G. Orive, R.M. Hernández, J.L. Pedraz.
P56: TOXICOLOGICAL STUDIES OF POLY (ANHYDRIDE) NANOPARTICLES FOR ORAL DRUG
DELIVERY
P. Ojer, A. López de Cerain, J.M. Irache.
P57: INFLUENCE OF CYCLODEXTRIN DERIVATIVES ON IN VITRO RELEASE OF
CYCLOSPORINE-A FROM POLY(ANHYDRIDE) NANOPARTICLES
M. Pecchio, P. Sanz-Ramos, H. Salman, J.M. Irache, M.J. Renedo, M.C. Dios-Viéitez.
P58: FORMULATION OPTIMISATION OF O/W NANOEMULSIONS USING AN STATISTICAL
ALGORITHM
T. Julianto, R. Pereira, N.I. Bukhari, K.H. Yuen, A.B.A. Majeed.
P59: RELEASE OF XANTHINES FROM EUDRAGIT RS PO AND EUDRAGIT RS PO-LACTOSA AS
RELATED TO DRUG AND MATRIX POLARITY
N. Aragón, P. Bustamante, B. Escalera, M.A. Peña.
P60:
INDIVIDUAL
CO-ENCAPSULATED
LIPOSOMAL
IMATINIB–MITOXANTRONE
COMBINATION FOR HORMONE-REFRACTORY PROSTATE CANCER THERAPY
A.C. Pinto, S. Ângelo, J.N. Moreira, S. Simões.
P61: CHARACTERIZATION OF INSULIN-LOADED POLY(LACTIC-COGLYCOLIC) ACID
MICROSPHERES. "IN VITRO" AND "IN VIVO" STUDIES.
C. Presmanes, C. Álvarez, J.J. Torrado.
P62: PRELIMINARY EVALUATION OF THE CROSS-LINKING EFFECT IN PECTIN-BASED DRUG
DELIVERY SYSTEMS
P.L. Mamani, R. Cardoso, M. Saiz, R. Ruiz, T. Marras, M.D. Veiga.
P63: INFLUENCE OF GELUCIRE(r) TYPE IN DISSOLUTION PROCESS
OF ACYCLOVIR
R. Ruiz, T. Marras, P.L. Mamani, M. Sáiz, M.D. Veiga.
P64: CHARACTERIZATION AND DISSOLUTION OF CAFFEINE BINARY AND TERNARY SOLID
DISPERSIONS: PRELIMINARY STUDY
M.I. Torres, R. Ruiz, M.D. Veiga.
P65: CONTINOUS RELEASE OF VEGF FROM MICROENCAPSULATED ENGINEERED CELLS FOR
ALZHEIMER DISEASE
A. Portero, R.M. Hernández, G. Orive, D. Antequera, C. Spuch, E. Carro, J.L. Pedraz.

P66: INVESTIGATION OF TEGAFUR LOADING AND RELEASE PROPERTIES OF CHITOSAN
NANOCAPSULES
J.L. Arias, M.A. Gómez-Barroso, M. López-Viota, M.A. Ruiz.
P67: CLIOQUINOL PLGA MICROSPHERES: OPTIMIZATION USING A FACTORIAL DESIGN
A. Salama, E. Barcia, C. Montejo, S. Negro.
P68:
ALGINATE-GANTREZ(
MICROSPHERES
CONTAINING
LIDOCAINE
HYDROCHLORIDE: PRODUCTION STAGES BY MEANS OF CLSM TECHNIQUES
S. Salas, A.M. Rabasco, M.L. González-Rodríguez.
P69: OPTIMIZATION OF FLUNARIZINE MICROSPHERES FOR THE TREATMENT OF MIGRAINE
V. Sandoval, S. Negro, E. Barcia.
P70: MANNITOL MICROSPHERES ARE ADEQUATE CARRIERS OF CHITOSAN/HYALURONIC
ACID NANOPARTICLES FOR LUNG DELIVERY
A. Grenha, R. Andriani, C. Remuñán-López, B. Seijo.
P71: TARGETED LIPOSOMES CARRYING SIRNA OR ASODN AGAINST BCR-ABL TO CHRONIC
MYELOID LEUKEMIA TREATMENT
L.S. Mendonça, F. Firmino, J.N. Moreira, M.C.P. Lima, S. Simões.
P72: DELIVERY OF ASODNS TO CHRONIC MYELOID LEUKEMIA BY TRANSFERRIN RECEPTOR
TARGETED LIPOSOMES
F. Firmino, L.S. Mendonça, J.N. Moreira, M.C.P. Lima, S. Simões.
P73: OVERCOMING RESISTANCE AND INCREASING SENSITIVENESS TO IMATINIB IN CML
THROUGH GENE SILENCING
L.S. Mendonça, M.C.P. Lima, S. Simões.
P74: DEVELOPMENT OF APLIDIN(r)-LOADED LIPOSOMES: DETERMINATION OF DRUG
CONTENT BY SOLID-PHASE EXTRACTION
B. Talero, S. Salas, M.L. González-Rodríguez, A.M. Rabasco.
P75: SWELLING STUDY OF AGAROSE SYSTEMS
T. Marras, P.L. Mamani, M. Sáiz, R. Ruiz, M.D. Veiga.
P76: MACROPHAGES POTENCIAL TARGETS OF PLGA-LABRAFIL DRUGS DELIVERY SYSTEMS
LOADED WITH INDOMETHACIN
S. Timón, A. Fernandez-Carballido, P. Pastoriza, C. Montejo.
P77: COMPARATIVE STUDIES OF ETHYLHEXYL METHOXYCINNAMATE DIFFUSION FROM
DIFFERENT KIND OF EMULSION W/O, O/W AND W1O/W2
E. Torres, A.C. Calpena, C. Barbé, L. Halbaut, M. Aróztegui.
P78: PHYSICAL STABILITY OF PLGA MICROPARTICLES FOR DNA ENCAPSULATION
I. Miguéliz, S. Díez, G. Navarro, C. Tros de Ilarduya.
P79:
INTERPLAY
SWELLING
ADHESION
PROPERTIES
POLYSACCHARIDE CAST FILMS IN DIFFERENT RESEMBLING MEDIA
F.J. Varum, A.W. Basit, J.J. Sousa, F. Veiga.
P80: PEGYLATED POLY(ANHYDRIDE) NANOPARTICLES FOR ORAL ADMINISTRATION OF
ANTICANCER DRUGS
V. Zabaleta, M.A. Campanero, J.M. Irache.

P81: MECHANISTIC CHARACTERIZATION OF THE CYTOTOXICITY OF CISPLATIN PLGA
NANOPARTICLES IN CULTURE CELLS
S. Zalba, D. Moreno, I. Navarro, C. Tros de Ilarduya, E. Bandrés, M.J. Garrido.
P82: IN VITRO-IN VIVO STUDY OF PARAQUAT MICROSPHERES TO DEVELOP A PROGRESSIVE
ANIMAL MODEL OF PARKINSON DISEASE
C. Évora, M. Rodríguez, E. Sánchez, A. Delgado, A. de León.
P83: A PROLINE-RICH PEPTIDE IMPROVES CELL TRANSFECTION OF SOLID LIPID
NANOPARTICLE-BASED NON-VIRAL VECTORS
A. del Pozo-Rodríguez, S. Pujals, D. Delgado, M.A. Solinís, A.R. Gascón, E. Giralt, J.L.
Pedraz.
Poster Presenter guidelines

All the posters will be displayed from the first session right through the Conference. Authors are required to be present at their poster during each Poster session, according Posters listed with odd number: Monday 20th October Posters listed with even number: Tuesday 21st October Poster Board

Poster boards will be on the same floor as main room. Poster locations correspond to the number assigned to each poster. Please consult with SPLC-CRS Conference staff at the Secretariat Desk if you have questions regarding the location of your poster board. SPLC-CRS Conference will provide supplies.

Source: http://www.splc-crs.org/congress2008/documentos/Guidelines%20Posters.pdf